CN108936622A - 双蛋白肠癌营养食品及其制备方法 - Google Patents
双蛋白肠癌营养食品及其制备方法 Download PDFInfo
- Publication number
- CN108936622A CN108936622A CN201810820028.8A CN201810820028A CN108936622A CN 108936622 A CN108936622 A CN 108936622A CN 201810820028 A CN201810820028 A CN 201810820028A CN 108936622 A CN108936622 A CN 108936622A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- raw material
- calcium
- intestinal cancer
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 61
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 60
- 201000002313 intestinal cancer Diseases 0.000 title claims abstract description 33
- 208000005016 Intestinal Neoplasms Diseases 0.000 title claims abstract description 32
- 239000002417 nutraceutical Substances 0.000 title claims abstract description 29
- 235000021436 nutraceutical agent Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 235000018102 proteins Nutrition 0.000 claims abstract description 59
- 108010058846 Ovalbumin Proteins 0.000 claims abstract description 20
- 229940092253 ovalbumin Drugs 0.000 claims abstract description 20
- 235000016709 nutrition Nutrition 0.000 claims abstract description 18
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 17
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 17
- 239000009429 Ginkgo biloba extract Substances 0.000 claims abstract description 12
- 229940068052 ginkgo biloba extract Drugs 0.000 claims abstract description 12
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims abstract description 12
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 9
- 230000035764 nutrition Effects 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 59
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 26
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 16
- 239000011575 calcium Substances 0.000 claims description 16
- 229960005069 calcium Drugs 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 14
- 229960003512 nicotinic acid Drugs 0.000 claims description 14
- 239000011664 nicotinic acid Substances 0.000 claims description 14
- 235000001968 nicotinic acid Nutrition 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 10
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 10
- 229960000304 folic acid Drugs 0.000 claims description 10
- 235000019152 folic acid Nutrition 0.000 claims description 10
- 239000011724 folic acid Substances 0.000 claims description 10
- 239000011772 phylloquinone Substances 0.000 claims description 10
- 239000011669 selenium Substances 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 235000015424 sodium Nutrition 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 235000013325 dietary fiber Nutrition 0.000 claims description 9
- 235000019197 fats Nutrition 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 229960003975 potassium Drugs 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 235000007686 potassium Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- 239000004475 Arginine Substances 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- 229910052804 chromium Inorganic materials 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 235000019192 riboflavin Nutrition 0.000 claims description 8
- 239000002151 riboflavin Substances 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 229940091258 selenium supplement Drugs 0.000 claims description 8
- 235000002639 sodium chloride Nutrition 0.000 claims description 8
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- 239000011691 vitamin B1 Substances 0.000 claims description 8
- 239000011726 vitamin B6 Substances 0.000 claims description 8
- 235000019166 vitamin D Nutrition 0.000 claims description 8
- 239000011710 vitamin D Substances 0.000 claims description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940045997 vitamin a Drugs 0.000 claims description 8
- 229940046008 vitamin d Drugs 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- 229920000294 Resistant starch Polymers 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000021323 fish oil Nutrition 0.000 claims description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 7
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 7
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 7
- 235000021254 resistant starch Nutrition 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 claims description 7
- 229910021555 Chromium Chloride Inorganic materials 0.000 claims description 6
- 239000011665 D-biotin Substances 0.000 claims description 6
- 235000000638 D-biotin Nutrition 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 6
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 6
- 239000001354 calcium citrate Substances 0.000 claims description 6
- 229960004256 calcium citrate Drugs 0.000 claims description 6
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical group [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 6
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 229910052748 manganese Inorganic materials 0.000 claims description 6
- 239000011572 manganese Substances 0.000 claims description 6
- 239000001508 potassium citrate Substances 0.000 claims description 6
- 229960002635 potassium citrate Drugs 0.000 claims description 6
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 6
- 235000011082 potassium citrates Nutrition 0.000 claims description 6
- 239000001230 potassium iodate Substances 0.000 claims description 6
- 235000006666 potassium iodate Nutrition 0.000 claims description 6
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical group [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 claims description 6
- 229940093930 potassium iodate Drugs 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 6
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 6
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 6
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 235000014692 zinc oxide Nutrition 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 claims description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 5
- 235000019483 Peanut oil Nutrition 0.000 claims description 5
- 241000201912 Suaeda Species 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 5
- 239000011666 cyanocobalamin Substances 0.000 claims description 5
- 229960002104 cyanocobalamin Drugs 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 230000037213 diet Effects 0.000 claims description 5
- 239000011773 ferrous fumarate Substances 0.000 claims description 5
- 235000002332 ferrous fumarate Nutrition 0.000 claims description 5
- 229960000225 ferrous fumarate Drugs 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 5
- 239000000395 magnesium oxide Substances 0.000 claims description 5
- 229940099596 manganese sulfate Drugs 0.000 claims description 5
- 239000011702 manganese sulphate Substances 0.000 claims description 5
- 235000007079 manganese sulphate Nutrition 0.000 claims description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 5
- 239000000312 peanut oil Substances 0.000 claims description 5
- 229960000342 retinol acetate Drugs 0.000 claims description 5
- 235000019173 retinyl acetate Nutrition 0.000 claims description 5
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 5
- 239000011770 retinyl acetate Substances 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 239000011653 vitamin D2 Substances 0.000 claims description 5
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 239000005717 Laminarin Substances 0.000 claims description 4
- 229920001543 Laminarin Polymers 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- 235000004347 Perilla Nutrition 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 229960001296 zinc oxide Drugs 0.000 claims description 3
- RZFHLOLGZPDCHJ-KTWAZNHYSA-N 2,5,7,8-tetramethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol Chemical compound OC1=C(C)C(C)=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-KTWAZNHYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims description 2
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 claims description 2
- DGUIQJBLMCNAIE-UHFFFAOYSA-N butanedioic acid;calcium Chemical compound [Ca].OC(=O)CCC(O)=O DGUIQJBLMCNAIE-UHFFFAOYSA-N 0.000 claims description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 2
- 235000011092 calcium acetate Nutrition 0.000 claims description 2
- 239000001639 calcium acetate Substances 0.000 claims description 2
- 229960005147 calcium acetate Drugs 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229960002713 calcium chloride Drugs 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 2
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 2
- 229940108925 copper gluconate Drugs 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 2
- 239000004222 ferrous gluconate Substances 0.000 claims description 2
- 229960001645 ferrous gluconate Drugs 0.000 claims description 2
- 235000013925 ferrous lactate Nutrition 0.000 claims description 2
- 239000004225 ferrous lactate Substances 0.000 claims description 2
- 229940037907 ferrous lactate Drugs 0.000 claims description 2
- 229960001604 ferrous succinate Drugs 0.000 claims description 2
- 229960001781 ferrous sulfate Drugs 0.000 claims description 2
- 239000011790 ferrous sulphate Substances 0.000 claims description 2
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 2
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000011683 manganese gluconate Substances 0.000 claims description 2
- 235000014012 manganese gluconate Nutrition 0.000 claims description 2
- 229940072543 manganese gluconate Drugs 0.000 claims description 2
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 229940108325 retinyl palmitate Drugs 0.000 claims description 2
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 2
- 239000011769 retinyl palmitate Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011746 zinc citrate Substances 0.000 claims description 2
- 235000006076 zinc citrate Nutrition 0.000 claims description 2
- 229940068475 zinc citrate Drugs 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 241000208140 Acer Species 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 8
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 235000004213 low-fat Nutrition 0.000 abstract description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 5
- 238000005810 carbonylation reaction Methods 0.000 description 5
- 241000219226 Acer truncatum Species 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 4
- 241000736199 Paeonia Species 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000006315 carbonylation Effects 0.000 description 4
- 230000001071 malnutrition Effects 0.000 description 4
- 235000000824 malnutrition Nutrition 0.000 description 4
- 208000015380 nutritional deficiency disease Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- -1 superoxide ion Chemical class 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 229920000377 Sinistrin Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical group 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- WWDMJSSVVPXVSV-YCNIQYBTSA-N retinyl ester Chemical compound CC1CCCC(C)(C)C1\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O WWDMJSSVVPXVSV-YCNIQYBTSA-N 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明属于营养食品技术领域,具体涉及一种双蛋白肠癌营养食品及其制备方法。所述的双蛋白肠癌营养食品中含有蛋白、脂肪、碳水化合物、维生素、矿物质、氨基酸、银杏黄酮、植物甾醇营养元素。本发明高蛋白、高碳水化合物、低脂肪的配方适合肠癌食用者身体特点,有利于身体康复。本发明以大豆蛋白和卵清蛋白相复合的形式,两种蛋白互相取长补短,为机体提供充足、全面的营养外,改进了产品的风味和状态,同时又能降低产品的成本。
Description
技术领域
本发明属于营养食品技术领域,具体涉及一种双蛋白肠癌营养食品及其制备方法。
背景技术
“双蛋白”是指植物蛋白与动物蛋白两者的有机结合。以优质大豆蛋白为基料、动植物蛋白相结合的营养健康型食品,是一种“新营养科学”的理念。动植物蛋白取长补短,使得营养价值明显提高,是补充蛋白营养的健康选择,能够使产品营养全面的同时,改进产品的风味和状态。
据世界卫生组织国际癌症研究中心(IARC)公布的资料显示,2012年全球肠癌的新发病例约136万例,占全部新发癌症病例的9.7%。中国医学科学院肿瘤医院/国家癌症中心的统计数据显示,我国2015年肠癌发病率、死亡率在全部恶性肿瘤中均位居前5位。
肿瘤患者营养不良的原因主要包括营养素摄入减少和代谢变化两种机制。研究表明,约20%的恶性肿瘤患者直接死于营养不良,营养不良严重影响患者的生存时间及生活质量。营养不良通常是由摄入量减少、生理活动下降、机体代谢紊乱引起,将严重影响临床预后。导致肿瘤患者生活质量下降、预后不良及增加肿瘤患者治疗的不良反应、增加感染的风险和死亡率。因此,提高癌症患者的营养状况十分重要,能帮助患者保持体重、减少化疗及放疗的不良反应、提高生活质量、延长肿瘤患者生存期。
因此,开发一种双蛋白肠癌营养食品具有重大的经济效益和社会意义。
发明内容
本发明的目的是提供一种双蛋白肠癌营养食品,以大豆蛋白和卵清蛋白相复合的形式,两种蛋白互相取长补短,为机体提供充足、全面的营养,同时又能降低产品的成本,改进产品状态,稳定性较好;本发明同时提供其制备方法。
本发明所述的双蛋白肠癌营养食品,每百克营养食品中营养成分如下:蛋白34-58g、脂肪1.3-4g、碳水化合物34-60g、维生素A 159-889μg、维生素D 4-13μg、维生素E 4-50mg、维生素K117-185μg、维生素B10.33-1mg、维生素B20.332-1mg、维生素B60.332-1mg、维生素B121-20μg、烟酸0.9-8mg、叶酸88-608μg、泛酸2-20mg、维生素C 3-7.2mg、生物素9-85μg、钠60-70mg、钾46-135mg、铜182-230μg、镁73-100mg、铁4-9mg、锌2-4.8mg、锰99-130μg、钙35-60mg、磷159-164mg、碘27-50μg、硒13-91μg、铬7-228μg、谷氨酰胺60-106mg、精氨酸100-150mg、银杏黄酮100-150mg、植物甾醇300-560mg。
其中:
蛋白的原料选自大豆蛋白和卵清蛋白组成的双蛋白;
脂肪的原料选自鱼油与大豆油、菜籽油、花生油、玉米籽油、红花油、紫苏油、翅果油、元宝枫籽油、牡丹籽油或地碱蓬籽油中的一种或多种;
碳水化合物的原料选自低聚木糖、低聚半乳糖、果糖、赤藓糖醇、海带多糖、麦芽糊精、羟丙基淀粉、膳食纤维或抗性淀粉中的一种或多种;果糖优选多聚果糖;膳食纤维优选豌豆膳食纤维;抗性淀粉优选豌豆抗性淀粉。
维生素A的原料选自醋酸视黄酯、棕榈酸视黄酯或β-胡萝卜素中的一种或多种;
维生素D的原料选自维生素D2或维生素D3中的一种或两种;
维生素E的原料选自D-α-生育三烯酚、dl-α-生育三烯酚、维生素E琥珀酸钙中的一种或多种;D-α-生育三烯酚优选D-α-醋酸生育三烯酚、D-α-琥珀酸生育三烯酚;dl-α-生育三烯酚优选dl-α-醋酸生育三烯酚;
维生素B1的原料选自盐酸硫胺素或硝酸硫胺素中的一种或两种;
维生素B2的原料选自核黄素或核黄素5’-磷酸钠中的一种或两种;
维生素B6的原料选自盐酸吡哆醇;
维生素B12的原料选自氰钴胺;
烟酸的原料选自烟酸或烟酰胺中的一种或两种;
泛酸的原料选自D-泛酸钙;
维生素C的原料选自L-抗坏血酸、L-抗坏血酸钠、L-抗坏血酸钙或抗坏血酸棕榈酸酯中的一种或多种;
生物素的原料选自D-生物素。
钠的原料选自氯化钠;
钾的原料选自磷酸氢二钾、磷酸二氢钾、氯化钾或柠檬酸钾中的一种或多种;
铜的原料选自硫酸铜或葡萄糖酸铜中的一种或两种;
镁的原料选自碳酸镁、硫酸镁、氧化镁、氯化镁或L-苏糖酸镁中的一种或多种;
铁的原料选自葡萄糖酸亚铁、富马酸亚铁、硫酸亚铁、乳酸亚铁或琥珀酸亚铁中的一种或多种;
锌的原料选自硫酸锌、柠檬酸锌、葡萄糖酸锌、氧化锌或乳酸锌中的一种或多种;
锰的原料选自硫酸锰或葡萄糖酸锰中的一种或两种;
钙的原料选自碳酸钙、醋酸钙、氯化钙、柠檬酸钙、葡萄糖酸钙、乳酸钙、磷酸氢钙、磷酸二氢钙、磷酸三钙、硫酸钙、L-乳酸钙或甘油磷酸钙中的一种或多种;
磷的原料选自磷酸二氢钾;
碘的原料选自碘酸钾;
硒的原料选自亚硒酸钠、富硒酵母或L-硒-甲基硒代半胱氨酸中的一种或多种;
铬的原料选自氯化铬。
本发明双蛋白的制备方法为:将卵清蛋白与大豆蛋白按质量比1:1-2.5的比例混合,形成物料,物料经超微粉碎工艺、微粒化工艺处理后得到双蛋白。
其中:
超微粉碎工艺为:在气流压力为0.85-0.95MPa,气流温度为10-15℃的条件下,控制气流式超微粉碎机的变频电机转速为14500-16500r/min,将物料粉碎至粒度为5-8μm的蛋白粉体;
微粒化工艺为:将蛋白粉体配成浓度为0.08-0.12g/mL的蛋白分散液,在85-95℃湿热处理25-35min后,采用转速为11000-14000r/min的高速乳化剪切机处理2-5min。
本发明所述的双蛋白肠癌营养食品的制备方法如下:以双蛋白肠癌营养食品质量100克计,将蛋白、碳水化合物、维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、维生素C、生物素、钠、钾、铜、镁、铁、锌、锰、钙、磷、碘、硒、铬、谷氨酰胺、精氨酸、银杏黄酮、植物甾醇营养成分的原料灭菌后,平均分成5份,形成功能袋;
脂肪营养成分的原料灭菌后,平均分成5份,形成能量袋。
其中:灭菌功率为400-500W,灭菌时间为100-120s。
本发明所述的双蛋白肠癌营养食品的食用方法如下:
目标人群的年龄为18-64岁,不包括孕妇和哺乳期妇女;
用量为:0.4袋/(kg·d),总量不超过27袋;
按照以下两种方法之一食用:
(1)用100-400mL的开水降温至50-60℃,加入功能袋和能量袋中的营养物质,搅拌、摇匀后,直接饮用或经管饲摄入;
(2)将功能袋中的营养物质添加到不含有食盐的日常饮食中食用,日常饮食中含有的脂肪与能量袋中的脂肪含量一致。
本发明产品的销售方式为直接销售给消费者,不通过医院、超市或药店等场所或途径,减少中间环节,降低费用,实现低价薄利销售的特点,消费者可以更经济、更实惠的食用,满足消费者长期食用的要求。
本发明的有益效果如下:
本发明双蛋白肠癌营养食品的效果取决于营养成分的各自作用和彼此间的协同作用。
本发明中,卵清蛋白是蛋清中最主要的蛋白质,主要的功能特性有乳化特性、起泡性、持水性和成膜性等,可作为乳化剂、保湿剂、凝胶剂等,在食品中起着改善食品的口感和质地、提高产品稳定性和延长保质期的作用。
大豆蛋白是营养价值最高的植物蛋白,不含胆固醇,基因结构接近人体氨基酸,价格便宜,但是其口感不佳,具有腥味,且溶解性不好。卵清蛋白具有口感佳、溶解性好的优点,但是其价格较高。配方中采用大豆蛋白和卵清蛋白的混合物的形式,结合了植物蛋白和动物蛋白两者优势,避免了单一蛋白的不足,又降低了原料成本。
重要地是,卵清蛋白的可吸收性比大豆蛋白强,而卵清蛋白相比大豆蛋白更易发生羰基化反应,羰基化反应会影响蛋白质的结构和功能,从而影响产品的色泽、风味、理化品质及功能特性。为了减少卵清蛋白发生羰基化反应,本发明采用大豆蛋白和卵清蛋白双蛋白复合的形式,通过添加大豆蛋白,使得后续加工中卵清蛋白发生羰基化反应时,大豆蛋白对卵清蛋白起到一定的保护作用。另外,在产品中添加的银杏黄酮为多酚类物质,亦可有效减轻产品中蛋白质羰基化反应,保证产品质量。
大豆蛋白与卵清蛋白经超微粉碎后,提高了蛋白颗粒的比表面积、表面能和孔隙率,从而增加了蛋白颗粒与油的接触面积,吸油性明显提高。超微粉碎导致蛋白内部疏水基团暴露,蛋白疏水性增强,乳化性和乳化稳定性提高;同时链段柔性的增加以及疏水基团、极性基团和-SH的充分暴露,增加了蛋白的起泡性及泡沫稳定性。因此,本发明利用超微粉碎工艺处理大豆蛋白与卵清蛋白,使得双蛋白具有更好的功能性质和溶解性。
脂肪的原料选自以富含ω-3不饱和脂肪酸为主的大豆油、菜籽油、花生油、玉米籽油、红花油、紫苏油、翅果油、元宝枫籽油、牡丹籽油或地碱蓬籽油中的一种或多种与鱼油按一定比例组成,这种搭配能够充分发挥ω-3不饱和脂肪酸改善细胞膜结构,改善细胞膜运输和免疫功能,促进T淋巴细胞免疫成熟的作用;此外,这些油通过合理搭配价格便宜、易得,其脂肪酸组成符合特定医用食品要求。
谷氨酰胺对肠癌化疗患者有显著的辅助治疗作用,同时可减少化疗的副作用。通过强抗氧化性可以从根源上选择性清除自由基,保留对肠癌细胞有杀死作用的超氧离子自由基,此外,氧化应激状态得到调整,也可以对改善肠癌患者血浆中ADA、GSH、PX、CAT、SOD、MDA的表达水平,从而调节患者的身体状态,有利于患者的康复、避免疾病的恶化或复发。
与其他功能性低聚糖相比较,低聚木糖具有良好的理化特性和双歧杆菌增殖特性。另外,低聚木糖还有抗氧化性、促进钙吸收、增强机体免疫力、降低肠癌等作用。赤藓糖醇、低聚半乳糖等可以改善饮食的口感,提高患者的胃口,降低化疗对患者的厌食影响,食用后可以改善患者的抑郁心情,同时与豌豆膳食纤维、抗性淀粉相结合调节肠胃,降低化疗带来的排便不畅等问题。羟丙基淀粉是良好的助悬剂,助悬效果好,不粘壁,易分散,絮凝颗粒细腻。麦芽糊精具有良好的溶解性,可改善产品的流动性。
精氨酸能够增强肠外营养,改善晚期肠癌化疗患者的免疫功能,作为保护肠黏膜的免疫屏障,效果明显。
本发明高蛋白、高碳水化合物、低脂肪的配方适合肠癌食用者身体特点,有利于身体康复。本发明以大豆蛋白和卵清蛋白相复合的形式,两种蛋白互相取长补短,为机体提供充足、全面的营养外,改进了产品的风味和状态,同时又能降低产品的成本。
具体实施方式
以下结合实施例对本发明做进一步描述。
实施例1
每百克双蛋白肠癌营养食品中营养成分如下:蛋白37g、脂肪2.5g、碳水化合物56.5g、维生素A 249.42μg、维生素D 5.2μg、维生素E 4mg、维生素K119μg、维生素B10.4mg、维生素B20.4mg、维生素B60.45mg、维生素B121μg、烟酸0.915mg、叶酸205μg、泛酸2.43mg、维生素C 7.2mg、生物素15μg、钠61.33mg、钾99.41mg、铜200μg、镁73.2mg、铁4.28mg、锌2.4mg、锰100.13μg、钙47.12mg、磷160.01mg、碘29.67μg、硒15.07μg、铬7.82μg、谷氨酰胺100mg、精氨酸150mg、银杏黄酮150mg、植物甾醇550mg。
制备每百克营养食品中的原料如下:
双蛋白37g、大豆油1g、牡丹籽油0.5g、地碱蓬籽油0.5g、鱼油0.5g、果糖30g、豌豆膳食纤维10g、羟丙基淀粉10g、低聚木糖5g、赤藓糖醇1.5g、醋酸视黄酯249.42μg、维生素D25.2μg、D-α-生育三烯酚4mg、维生素K119μg、盐酸硫胺素0.4mg、核黄素0.4mg、盐酸吡哆醇0.45mg、氰钴胺1μg、烟酸0.915mg、叶酸205μg、D-泛酸钙2.7mg、L-抗坏血酸7.2mg、D-生物素15μg、氯化钠156.05mg、柠檬酸钾190.03mg、硫酸铜499.59μg、氧化镁122mg、富马酸亚铁13.01mg、氧化锌2.99mg、硫酸锰0.4mg、柠檬酸钙224.36mg、磷酸二氢钾727.32mg、碘酸钾50.28μg、亚硒酸钠33.04μg、氯化铬39.1μg、谷氨酰胺100mg、精氨酸150mg、银杏黄酮150mg、植物甾醇550mg。
其中:
双蛋白的制备方法为:将大豆蛋白25g与卵清蛋白12g混合,形成物料,在气流压力为0.85MPa,气流温度为10℃的条件下,控制气流式超微粉碎机的变频电机转速为14500r/min,将物料粉碎至粒度为5μm的蛋白粉体;将蛋白粉体配成浓度为0.10g/mL的蛋白分散液,在90℃湿热处理30min后,采用转速为11000r/min的高速乳化剪切机处理4min,得到双蛋白。
制备方法如下:
将双蛋白、果糖、豌豆膳食纤维、羟丙基淀粉、低聚木糖、赤藓糖醇、醋酸视黄酯、维生素、D-α-生育三烯酚、维生素K1、盐酸硫胺素、核黄素、盐酸吡哆醇、氰钴胺、烟酸、叶酸、D-泛酸钙、L-抗坏血酸、D-生物素、氯化钠、柠檬酸钾、硫酸铜、氧化镁、富马酸亚铁、氧化锌、硫酸锰、柠檬酸钙、磷酸二氢钾、碘酸钾、亚硒酸钠、氯化铬、谷氨酰胺、精氨酸、银杏黄酮、植物甾醇,于500W的灭菌器中灭菌100s,灭菌后,平均分成5份,形成功能袋;
将大豆油、牡丹籽油、地碱蓬籽油、鱼油于500W的灭菌器中灭菌100s,灭菌后,平均分成5份,形成能量袋。
实施例2
每百克双蛋白肠癌营养食品中营养成分如下:蛋白40g、脂肪2.6g、碳水化合物55g、维生素A 287.79μg、维生素D 10μg、维生素E 5mg、维生素K122μg、维生素B10.45mg、维生素B20.5mg、维生素B60.6mg、维生素B122μg、烟酸1.8mg、叶酸400μg、泛酸2.52mg、维生素C3.5mg、生物素12μg、钠64.87mg、钾99.415mg、铜220μg、镁75mg、铁8.56mg、锌2.56mg、锰100.13μg、钙52.36mg、磷160.01mg、碘30μg、硒45.66μg、铬156.4μg、谷氨酰胺100mg、精氨酸150mg、银杏黄酮150mg、植物甾醇400mg。
制备每百克营养食品中的原料如下:
双蛋白40g、花生油0.5g、玉米籽油0.5g、翅果油0.5g、元宝枫籽油0.5g、鱼油0.6g、果糖10g、豌豆膳食纤维20g、海带多糖5g、羟丙基淀粉5g、豌豆抗性淀粉10g、赤藓糖醇5g、醋酸视黄酯287.79μg、维生素D210μg、D-α-生育三烯酚5mg、维生素K122μg、盐酸硫胺素450μg、核黄素500μg、盐酸吡哆醇600μg、氰钴胺2μg、烟酸1.8mg、叶酸400μg、D-泛酸钙2.8mg、L-抗坏血酸3.5mg、D-生物素12μg、氯化钠165.06mg、柠檬酸钾189.93mg、硫酸铜549.55μg、氧化镁125mg、富马酸亚铁26.02mg、氧化锌3.19mg、硫酸锰0.4mg、柠檬酸钙249.31mg、磷酸二氢钾727.32mg、碘酸钾50.84μg、亚硒酸钠100.13μg、氯化铬782μg、谷氨酰胺100mg、精氨酸150mg、银杏黄酮150mg、植物甾醇400mg。
其中:
双蛋白的制备方法为:将大豆蛋白20g与卵清蛋白20g混合,形成物料,在气流压力为0.95MPa,气流温度为15℃的条件下,控制气流式超微粉碎机的变频电机转速为16500r/min,将物料粉碎至粒度为8μm的蛋白粉体;将蛋白粉体配成浓度为0.12g/mL的蛋白分散液,在95℃湿热处理35min后,采用转速为14000r/min的高速乳化剪切机处理4min,得到双蛋白。
制备方法如下:
将双蛋白、果糖、豌豆膳食纤维、海带多糖、羟丙基淀粉、豌豆抗性淀粉、赤藓糖醇、醋酸视黄酯、维生素D2、D-α-生育三烯酚、维生素K1、盐酸硫胺素、核黄素、盐酸吡哆醇、氰钴胺、烟酸、叶酸、D-泛酸钙、L-抗坏血酸、D-生物素、氯化钠、柠檬酸钾、硫酸铜、氧化镁、富马酸亚铁、氧化锌、硫酸锰、柠檬酸钙、磷酸二氢钾、碘酸钾、亚硒酸钠、氯化铬、谷氨酰胺、精氨酸、银杏黄酮、植物甾醇,于425W的灭菌器中灭菌120s,灭菌后,平均分成5份,形成功能袋;
将花生油、玉米籽油、翅果油、元宝枫籽油、鱼油于425W的灭菌器中灭菌120s,灭菌后,平均分成5份,形成能量袋。
Claims (10)
1.一种双蛋白肠癌营养食品,其特征在于每百克营养食品中营养成分如下:蛋白34-58g、脂肪1.3-4g、碳水化合物34-60g、维生素A 159-889μg、维生素D 4-13μg、维生素E 4-50mg、维生素K1 17-185μg、维生素B1 0.33-1mg、维生素B2 0.332-1mg、维生素B6 0.332-1mg、维生素B12 1-20μg、烟酸0.9-8mg、叶酸88-608μg、泛酸2-20mg、维生素C 3-7.2mg、生物素9-85μg、钠60-70mg、钾46-135mg、铜182-230μg、镁73-100mg、铁4-9mg、锌2-4.8mg、锰99-130μg、钙35-60mg、磷159-164mg、碘27-50μg、硒13-91μg、铬7-228μg、谷氨酰胺60-106mg、精氨酸100-150mg、银杏黄酮100-150mg、植物甾醇300-560mg。
2.根据权利要求1所述的双蛋白肠癌营养食品,其特征在于:
蛋白的原料选自大豆蛋白和卵清蛋白组成的双蛋白;
脂肪的原料选自鱼油与大豆油、菜籽油、花生油、玉米籽油、红花油、紫苏油、翅果油、元宝枫籽油、牡丹籽油或地碱蓬籽油中的一种或多种;
碳水化合物的原料选自低聚木糖、低聚半乳糖、果糖、赤藓糖醇、海带多糖、麦芽糊精、羟丙基淀粉、膳食纤维或抗性淀粉中的一种或多种。
3.根据权利要求1所述的双蛋白肠癌营养食品,其特征在于:
维生素A的原料选自醋酸视黄酯、棕榈酸视黄酯或β-胡萝卜素中的一种或多种;
维生素D的原料选自维生素D2或维生素D3中的一种或两种;
维生素E的原料选自D-α-生育三烯酚、dl-α-生育三烯酚或维生素E琥珀酸钙中的一种或多种;
维生素B1的原料选自盐酸硫胺素或硝酸硫胺素中的一种或两种;
维生素B2的原料选自核黄素或核黄素5’-磷酸钠中的一种或两种;
维生素B6的原料选自盐酸吡哆醇;
维生素B12的原料选自氰钴胺;
烟酸的原料选自烟酸或烟酰胺中的一种或两种;
泛酸的原料选自D-泛酸钙;
维生素C的原料选自L-抗坏血酸、L-抗坏血酸钠、L-抗坏血酸钙或抗坏血酸棕榈酸酯中的一种或多种;
生物素的原料选自D-生物素。
4.根据权利要求1所述的双蛋白肠癌营养食品,其特征在于:
钠的原料选自氯化钠;
钾的原料选自磷酸氢二钾、磷酸二氢钾、氯化钾或柠檬酸钾中的一种或多种;
铜的原料选自硫酸铜或葡萄糖酸铜中的一种或两种;
镁的原料选自碳酸镁、硫酸镁、氧化镁、氯化镁或L-苏糖酸镁中的一种或多种;
铁的原料选自葡萄糖酸亚铁、富马酸亚铁、硫酸亚铁、乳酸亚铁或琥珀酸亚铁中的一种或多种;
锌的原料选自硫酸锌、柠檬酸锌、葡萄糖酸锌、氧化锌或乳酸锌中的一种或多种;
锰的原料选自硫酸锰或葡萄糖酸锰中的一种或两种;
钙的原料选自碳酸钙、醋酸钙、氯化钙、柠檬酸钙、葡萄糖酸钙、乳酸钙、磷酸氢钙、磷酸二氢钙、磷酸三钙、硫酸钙、L-乳酸钙或甘油磷酸钙中的一种或多种;
磷的原料选自磷酸二氢钾;
碘的原料选自碘酸钾;
硒的原料选自亚硒酸钠、富硒酵母或L-硒-甲基硒代半胱氨酸中的一种或多种;
铬的原料选自氯化铬。
5.根据权利要求2所述的双蛋白肠癌营养食品,其特征在于:双蛋白的制备方法为:将卵清蛋白与大豆蛋白按质量比1:1-2.5的比例混合,形成物料,物料经超微粉碎工艺、微粒化工艺处理后得到双蛋白。
6.根据权利要求5所述的双蛋白肠癌营养食品,其特征在于:
超微粉碎工艺为:在气流压力为0.85-0.95MPa,气流温度为10-15℃的条件下,控制气流式超微粉碎机的变频电机转速为14500-16500r/min,将物料粉碎至粒度为5-8μm的蛋白粉体;
微粒化工艺为:将蛋白粉体配成浓度为0.08-0.12g/mL的蛋白分散液,在85-95℃湿热处理25-35min后,采用转速为11000-14000r/min的高速乳化剪切机处理2-5min。
7.一种权利要求1所述的双蛋白肠癌营养食品的制备方法,其特征在于:以双蛋白肠癌营养食品质量100克计,将蛋白、碳水化合物、维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、维生素C、生物素、钠、钾、铜、镁、铁、锌、锰、钙、磷、碘、硒、铬、谷氨酰胺、精氨酸、银杏黄酮、植物甾醇营养成分的原料灭菌后,平均分成5份,形成功能袋;
脂肪营养成分的原料灭菌后,平均分成5份,形成能量袋。
8.根据权利要求7所述的双蛋白肠癌营养食品的制备方法,其特征在于:灭菌功率为400-500W,灭菌时间为100-120s。
9.一种权利要求1所述的双蛋白肠癌营养食品的食用方法,其特征在于:
目标人群的年龄为18-64岁,不包括孕妇和哺乳期妇女;
用量为:0.4袋/(kg·d),总量不超过27袋;
按照以下两种方法之一食用:
(1)用100-400mL的开水降温至50-60℃,加入功能袋和能量袋中的营养物质,搅拌、摇匀后,直接饮用或经管饲摄入;
(2)将功能袋中的营养物质添加到不含有食盐的日常饮食中食用,日常饮食中含有的脂肪与能量袋中的脂肪含量一致。
10.一种权利要求1所述的双蛋白肠癌营养食品的销售方式,其特征在于:销售方式为不通过医院、超市或药店,直接销售给消费者。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810820028.8A CN108936622A (zh) | 2018-07-24 | 2018-07-24 | 双蛋白肠癌营养食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810820028.8A CN108936622A (zh) | 2018-07-24 | 2018-07-24 | 双蛋白肠癌营养食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108936622A true CN108936622A (zh) | 2018-12-07 |
Family
ID=64463541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810820028.8A Pending CN108936622A (zh) | 2018-07-24 | 2018-07-24 | 双蛋白肠癌营养食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108936622A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112293560A (zh) * | 2019-07-25 | 2021-02-02 | 中粮集团有限公司 | 一种速溶大豆蛋白组合物及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660406A (zh) * | 2004-12-16 | 2005-08-31 | 广东省农业科学院农业生物技术研究所 | 一种短肽型肠内营养乳剂及其加工方法 |
CN103330215A (zh) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | 一种适用于肿瘤患者的营养配方食品 |
CN104605031A (zh) * | 2014-11-13 | 2015-05-13 | 天津科技大学 | 一种复合型脂肪模拟物及其制备方法 |
CN106473153A (zh) * | 2016-09-21 | 2017-03-08 | 河南汇博医疗股份有限公司 | 全营养配方食品及其制备方法 |
CN108157953A (zh) * | 2018-01-19 | 2018-06-15 | 山东理工大学 | 一种全营养配方食品及其制备方法 |
CN108936597A (zh) * | 2018-05-08 | 2018-12-07 | 山东理工大学 | 一种直肠癌营养食品及其制备方法 |
CN109043505A (zh) * | 2018-07-03 | 2018-12-21 | 麦孚营养科技(北京)有限公司 | 海洋鱼低聚肽低渣营养配方制品、其制备方法及其用途 |
-
2018
- 2018-07-24 CN CN201810820028.8A patent/CN108936622A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660406A (zh) * | 2004-12-16 | 2005-08-31 | 广东省农业科学院农业生物技术研究所 | 一种短肽型肠内营养乳剂及其加工方法 |
CN103330215A (zh) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | 一种适用于肿瘤患者的营养配方食品 |
CN104605031A (zh) * | 2014-11-13 | 2015-05-13 | 天津科技大学 | 一种复合型脂肪模拟物及其制备方法 |
CN106473153A (zh) * | 2016-09-21 | 2017-03-08 | 河南汇博医疗股份有限公司 | 全营养配方食品及其制备方法 |
CN108157953A (zh) * | 2018-01-19 | 2018-06-15 | 山东理工大学 | 一种全营养配方食品及其制备方法 |
CN108936597A (zh) * | 2018-05-08 | 2018-12-07 | 山东理工大学 | 一种直肠癌营养食品及其制备方法 |
CN109043505A (zh) * | 2018-07-03 | 2018-12-21 | 麦孚营养科技(北京)有限公司 | 海洋鱼低聚肽低渣营养配方制品、其制备方法及其用途 |
Non-Patent Citations (1)
Title |
---|
牙韩清等: "谷氨酰胺、精氨酸强化的全胃肠外营养对结直肠癌术后患者免疫功能的影响 ", 《肿瘤防治研究》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112293560A (zh) * | 2019-07-25 | 2021-02-02 | 中粮集团有限公司 | 一种速溶大豆蛋白组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6413545B1 (en) | Diet composition and method of weight management | |
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN108185437A (zh) | 一种肿瘤全营养配方粉及其制备方法 | |
CN108936621A (zh) | 双蛋白全营养配方食品及其制备方法 | |
CN110226744A (zh) | 一种前列腺炎专用型临床营养配方及其制备方法 | |
CN105054163B (zh) | 维生素可吸果冻饮料及其制备方法 | |
CN109393493A (zh) | 一种含hmb钙的预消化型全营养液及其制备方法 | |
CN108391811A (zh) | 一种肿瘤全营养配方食品及其应用 | |
CN108157953A (zh) | 一种全营养配方食品及其制备方法 | |
CN108936595A (zh) | 结肠癌营养食品及其制备方法 | |
CN108719977A (zh) | 一种乳腺癌营养食品及其制备方法 | |
CN109123660A (zh) | 一种用于孕妇营养品的核桃乳清蛋白复合粉及其制备方法 | |
CN108308597A (zh) | 一种营养不良专用型临床营养配方及其制备方法 | |
CN108936597A (zh) | 一种直肠癌营养食品及其制备方法 | |
CN110214942A (zh) | 一种甲亢专用型医学营养配方及其制备方法 | |
KR20110119305A (ko) | 타우린, 비타민류, 로얄젤리, 홍삼, 구기자, 글루메이트 (탈지미강, 미베아) 및 애플 에센스를 주성분으로 함유하는 기능성 음료조성물 | |
CN107007646A (zh) | 一种辅助防治癌症的营养复合物 | |
CN108741086A (zh) | 一种适于长期健身的运动补剂及其制备方法 | |
CN108936622A (zh) | 双蛋白肠癌营养食品及其制备方法 | |
CN1255052C (zh) | 含有微量元素和维生素的食品 | |
CN106923342A (zh) | 一种富硒百香果氨基酸含片及其制作方法 | |
CN103271353B (zh) | 一种护肝保健组合物及其制备方法 | |
JP2007244325A (ja) | 新しい健康食品 | |
CN108936596A (zh) | 肺癌营养食品及其制备方法 | |
CN108936623A (zh) | 双蛋白胃癌全营养配方食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181207 |
|
RJ01 | Rejection of invention patent application after publication |